Follow
Weihua Guo
Weihua Guo
Staff Scientist I, Department of Immuno-Oncology, Beckman Research Institute, City of Hope
Verified email at coh.org
Title
Cited by
Cited by
Year
Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients
CA Egelston, C Avalos, TY Tu, A Rosario, R Wang, S Solomon, ...
JCI insight 4 (19), 2019
932019
Investigating strain dependency in the production of aromatic compounds in Saccharomyces cerevisiae
M Suástegui, W Guo, X Feng, Z Shao
Biotechnology and Bioengineering 113 (12), 2676-2685, 2016
682016
Mini-review: in vitro metabolic engineering for biomanufacturing of high-value products
W Guo, J Sheng, X Feng
Computational and Structural Biotechnology Journal 15, 161-167, 2017
672017
Metabolic engineering of Saccharomyces cerevisiae to produce 1-hexadecanol from xylose
W Guo, J Sheng, H Zhao, X Feng
Microbial cell factories 15, 1-11, 2016
612016
A phase II clinical trial of pembrolizumab and enobosarm in patients with androgen receptor‐positive metastatic triple‐negative breast cancer
Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ...
The oncologist 26 (2), 99-e217, 2021
562021
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer
Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ...
European Journal of Cancer 154, 11-20, 2021
432021
13C Pathway Analysis for the Role of Formate in Electricity Generation by Shewanella Oneidensis MR-1 Using Lactate in Microbial Fuel Cells
S Luo, W Guo, K H. Nealson, X Feng, Z He
Scientific reports 6 (1), 20941, 2016
392016
DeepMetabolism: a deep learning system to predict phenotype from genome sequencing
W Guo, Y Xu, X Feng
arXiv preprint arXiv:1705.03094, 2017
272017
OM-FBA: integrate transcriptomics data with flux balance analysis to decipher the cell metabolism
W Guo, X Feng
PloS one 11 (4), e0154188, 2016
252016
Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer
CA Egelston, W Guo, J Tan, C Avalos, DL Simons, MH Lim, YJ Huang, ...
JCI insight 7 (3), 2022
202022
Investigate the Metabolic Reprogramming of Saccharomyces cerevisiae for Enhanced Resistance to Mixed Fermentation Inhibitors via 13C Metabolic Flux Analysis
W Guo, Y Chen, N Wei, X Feng
PLoS One 11 (8), e0161448, 2016
202016
13C-Metabolic Flux Analysis: An Accurate Approach to Demystify Microbial Metabolism for Biochemical Production
W Guo, J Sheng, X Feng
Bioengineering 3 (1), 3, 2015
202015
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive …
C Egelston, W Guo, S Yost, JS Lee, D Rose, C Avalos, J Ye, P Frankel, ...
Journal for Immunotherapy of Cancer 9 (3), 2021
192021
PD-L1 and ICOSL discriminate human secretory and helper dendritic cells in cancer, allergy and autoimmunity
C Hoffmann, F Noel, M Grandclaudon, L Massenet-Regad, P Michea, ...
Nature Communications 13 (1), 1983, 2022
142022
Synergizing 13C Metabolic Flux Analysis and Metabolic Engineering for Biochemical Production
W Guo, J Sheng, X Feng
Synthetic Biology–Metabolic Engineering, 265-299, 2018
142018
13 C pathway analysis of biofilm metabolism of Shewanella oneidensis MR-1
W Guo, S Luo, Z He, X Feng
RSC Advances 5 (50), 39840-39843, 2015
142015
Investigating oxalate biosynthesis in the wood-decaying fungus Gloeophyllum trabeum using 13 C metabolic flux analysis
L Zhuang, W Guo, M Yoshida, X Feng, B Goodell
Rsc Advances 5 (126), 104043-104047, 2015
122015
Genomic markers of CDK 4/6 inhibitor resistance in hormone receptor positive metastatic breast cancer
JS Lee, SE Yost, SM Li, Y Cui, PH Frankel, YC Yuan, D Schmolze, ...
Cancers 14 (13), 3159, 2022
92022
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
CA Egelston, W Guo, SE Yost, X Ge, JS Lee, PH Frankel, Y Cui, C Ruel, ...
Cancer Immunology, Immunotherapy 72 (9), 3013-3027, 2023
72023
Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade
M Mei, L Chen, J Godfrey, J Song, C Egelston, S Puverel, LE Budde, ...
Blood 142 (16), 1359-1370, 2023
42023
The system can't perform the operation now. Try again later.
Articles 1–20